Sintilimab Treatment for Chronic Active Epstein–Barr Virus Infection and Epstein–Barr Virus-Associated Hemophagocytic Lymphohistiocytosis in Children

Ruyue Chen,Qiang Lin,Yun Zhu,Yunyan Shen,Qinying Xu,Hanyun Tang,Ningxun Cui,Lu Jiang,Xiaomei Dai,Weiqing Chen,Xiaozhong Li

ORPHANET JOURNAL OF RARE DISEASES（2023）

Cited 0|Views11

Key words

Epstein–Barr virus (EBV),Chronic active Epstein–Barr virus infection (CAEBV),Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH),Programmed cell death 1 (PD-1),Sintilimab

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined